---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-011852"
form_type: "8-K"
ticker: "KALA"
cik: "0001479419"
company_name: "KALA BIO, Inc."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T22:48:46.363494+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kala Bio CEO Mark Iwicki resigns; Todd Bazemore named interim CEO

## Summary
- Mark Iwicki resigned as CEO effective Feb 11, 2025; remains Chair of Board.
- Board appointed Todd Bazemore as interim CEO and principal executive officer, effective immediately.
- Bazemore had been President since Dec 2021 and COO since Nov 2017.
- Prior roles include EVP/COO at Santhera and EVP/Chief Commercial Officer at Dyax.

## SEC filing metadata
- accession: 0001104659-25-011852
- form_type: 8-K
- ticker: KALA
- cik: 0001479419
- company_name: KALA BIO, Inc.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479419/000110465925011852/0001104659-25-011852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479419/000110465925011852/tm256232d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-011852
- JSON: https://secwatch.observer/filing/0001104659-25-011852.json
- Plain text: https://secwatch.observer/filing/0001104659-25-011852.txt

## Key facts
- Executive change
  Mark Iwicki resigned as Chief Executive Officer at KALA BIO, Inc..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: On February 11, 2025, Mark Iwicki notified KALA BIO, Inc. (the “Company”) of his decision to resign as the Chief Executive Officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000110465925011852/0001104659-25-011852-index.htm
- Executive change
  Todd Bazemore was appointed as interim Chief Executive Officer and principal executive officer at KALA BIO, Inc..
  - Action: appointed
  - Role: interim Chief Executive Officer and principal executive officer
  source text: On February 11, 2025, the Board appointed Todd Bazemore as the interim Chief Executive Officer and principal executive officer of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479419/000110465925011852/0001104659-25-011852-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.